APO Research
Talk to an analyst

APO RESEARCH · REPORT

Interventional Pulmonology Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Interventional Pulmonology Device Market Outlook and Growth Opportunities 2026

8 January 2026206 pages

Choose your research edition.

Industry ResearchInterventional Pulmonology Device Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Interventional Pulmonology Device Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Interventional Pulmonology Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Interventional Pulmonology Device Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Interventional Pulmonology Device Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Interventional Pulmonology Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Interventional Pulmonology Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Interventional Pulmonology Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Interventional Pulmonology Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Interventional Pulmonology Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Interventional Pulmonology Device market include Boston Scientific, Olympus, Medtronic, Ambu A/S, Pentax (HOYA), Micro Tech, Fujifilm, CONMED and Teleflex Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Interventional Pulmonology Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Interventional Pulmonology Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Interventional Pulmonology Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Interventional Pulmonology Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Interventional Pulmonology Device Segment by Company

Boston Scientific

Olympus

Medtronic

Ambu A/S

Pentax (HOYA)

Micro Tech

Fujifilm

CONMED

Teleflex Medical

ICU Medical

Medi-Globe

Merit Medical Systems

TRACOE medical

Karl Storz

Verathon

Well Lead

TuoRen

Interventional Pulmonology Device Segment by Type

Bronchoscope

Pleuroscopy

Respiratory Endotherapy Devices

IP Therapeutic Device

Tracheostomy Tube

Interventional Pulmonology Device Segment by Application

Hospital and Clinic

Ambulatory Surgical Centers

Interventional Pulmonology Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Interventional Pulmonology Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Interventional Pulmonology Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Interventional Pulmonology Device significant trends, drivers, influence factors in global and regions.

6. To analyze Interventional Pulmonology Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Interventional Pulmonology Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Interventional Pulmonology Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Interventional Pulmonology Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Interventional Pulmonology Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Interventional Pulmonology Device industry.

Chapter 3: Detailed analysis of Interventional Pulmonology Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Interventional Pulmonology Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Interventional Pulmonology Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Interventional Pulmonology Device Industry Trends Table 2. Interventional Pulmonology Device Industry Drivers Table 3. Interventional Pulmonology Device Industry Opportunities and Challenges Table 4. Interventional Pulmonology Device Industry Restraints Table 5. Global Interventional Pulmonology Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Interventional Pulmonology Device Revenue Share by Company (2021-2026) Table 7. Global Interventional Pulmonology Device Sales Volume by Company (k units) & (2021-2026) Table 8. Global Interventional Pulmonology Device Sales Volume Share by Company (2021-2026) Table 9. Global Interventional Pulmonology Device Average Price (USD/unit) of Company (2021-2026) Table 10. Global Interventional Pulmonology Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Interventional Pulmonology Device Key Company Manufacturing Base & Headquarters Table 12. Global Interventional Pulmonology Device Company, Product Type & Application Table 13. Global Interventional Pulmonology Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Interventional Pulmonology Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Bronchoscope Table 18. Significant Companies of Pleuroscopy Table 19. Significant Companies of Respiratory Endotherapy Devices Table 20. Significant Companies of IP Therapeutic Device Table 21. Significant Companies of Tracheostomy Tube Table 22. Global Interventional Pulmonology Device Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Interventional Pulmonology Device Sales Volume by Type (2021-2026) & (k units) Table 24. Global Interventional Pulmonology Device Sales Volume by Type (2027-2032) & (k units) Table 25. Global Interventional Pulmonology Device Sales Volume Share by Type (2021-2026) Table 26. Global Interventional Pulmonology Device Sales Volume Share by Type (2027-2032) Table 27. Global Interventional Pulmonology Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Interventional Pulmonology Device Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Interventional Pulmonology Device Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Interventional Pulmonology Device Sales Value Share by Type (2021-2026) Table 31. Global Interventional Pulmonology Device Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital and Clinic Table 33. Significant Companies of Ambulatory Surgical Centers Table 34. Global Interventional Pulmonology Device Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Interventional Pulmonology Device Sales Volume by Application (2021-2026) & (k units) Table 36. Global Interventional Pulmonology Device Sales Volume by Application (2027-2032) & (k units) Table 37. Global Interventional Pulmonology Device Sales Volume Share by Application (2021-2026) Table 38. Global Interventional Pulmonology Device Sales Volume Share by Application (2027-2032) Table 39. Global Interventional Pulmonology Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Interventional Pulmonology Device Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Interventional Pulmonology Device Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Interventional Pulmonology Device Sales Value Share by Application (2021-2026) Table 43. Global Interventional Pulmonology Device Sales Value Share by Application (2027-2032) Table 44. Global Interventional Pulmonology Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Interventional Pulmonology Device Sales by Region (2021-2026) & (k units) Table 46. Global Interventional Pulmonology Device Sales Market Share by Region (2021-2026) Table 47. Global Interventional Pulmonology Device Sales by Region (2027-2032) & (k units) Table 48. Global Interventional Pulmonology Device Sales Market Share by Region (2027-2032) Table 49. Global Interventional Pulmonology Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Interventional Pulmonology Device Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Interventional Pulmonology Device Sales Value Share by Region (2021-2026) Table 52. Global Interventional Pulmonology Device Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Interventional Pulmonology Device Sales Value Share by Region (2027-2032) Table 54. Global Interventional Pulmonology Device Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Interventional Pulmonology Device Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Interventional Pulmonology Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Interventional Pulmonology Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Interventional Pulmonology Device Sales by Country (2021-2026) & (k units) Table 59. Global Interventional Pulmonology Device Sales Market Share by Country (2021-2026) Table 60. Global Interventional Pulmonology Device Sales by Country (2027-2032) & (k units) Table 61. Global Interventional Pulmonology Device Sales Market Share by Country (2027-2032) Table 62. Global Interventional Pulmonology Device Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Interventional Pulmonology Device Sales Value Market Share by Country (2021-2026) Table 64. Global Interventional Pulmonology Device Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Interventional Pulmonology Device Sales Value Market Share by Country (2027-2032) Table 66. Boston Scientific Company Information Table 67. Boston Scientific Business Overview Table 68. Boston Scientific Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Boston Scientific Interventional Pulmonology Device Product Portfolio Table 70. Boston Scientific Recent Development Table 71. Olympus Company Information Table 72. Olympus Business Overview Table 73. Olympus Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Olympus Interventional Pulmonology Device Product Portfolio Table 75. Olympus Recent Development Table 76. Medtronic Company Information Table 77. Medtronic Business Overview Table 78. Medtronic Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Medtronic Interventional Pulmonology Device Product Portfolio Table 80. Medtronic Recent Development Table 81. Ambu A/S Company Information Table 82. Ambu A/S Business Overview Table 83. Ambu A/S Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Ambu A/S Interventional Pulmonology Device Product Portfolio Table 85. Ambu A/S Recent Development Table 86. Pentax (HOYA) Company Information Table 87. Pentax (HOYA) Business Overview Table 88. Pentax (HOYA) Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Pentax (HOYA) Interventional Pulmonology Device Product Portfolio Table 90. Pentax (HOYA) Recent Development Table 91. Micro Tech Company Information Table 92. Micro Tech Business Overview Table 93. Micro Tech Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Micro Tech Interventional Pulmonology Device Product Portfolio Table 95. Micro Tech Recent Development Table 96. Fujifilm Company Information Table 97. Fujifilm Business Overview Table 98. Fujifilm Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Fujifilm Interventional Pulmonology Device Product Portfolio Table 100. Fujifilm Recent Development Table 101. CONMED Company Information Table 102. CONMED Business Overview Table 103. CONMED Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. CONMED Interventional Pulmonology Device Product Portfolio Table 105. CONMED Recent Development Table 106. Teleflex Medical Company Information Table 107. Teleflex Medical Business Overview Table 108. Teleflex Medical Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Teleflex Medical Interventional Pulmonology Device Product Portfolio Table 110. Teleflex Medical Recent Development Table 111. ICU Medical Company Information Table 112. ICU Medical Business Overview Table 113. ICU Medical Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. ICU Medical Interventional Pulmonology Device Product Portfolio Table 115. ICU Medical Recent Development Table 116. Medi-Globe Company Information Table 117. Medi-Globe Business Overview Table 118. Medi-Globe Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Medi-Globe Interventional Pulmonology Device Product Portfolio Table 120. Medi-Globe Recent Development Table 121. Merit Medical Systems Company Information Table 122. Merit Medical Systems Business Overview Table 123. Merit Medical Systems Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Merit Medical Systems Interventional Pulmonology Device Product Portfolio Table 125. Merit Medical Systems Recent Development Table 126. TRACOE medical Company Information Table 127. TRACOE medical Business Overview Table 128. TRACOE medical Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. TRACOE medical Interventional Pulmonology Device Product Portfolio Table 130. TRACOE medical Recent Development Table 131. Karl Storz Company Information Table 132. Karl Storz Business Overview Table 133. Karl Storz Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Karl Storz Interventional Pulmonology Device Product Portfolio Table 135. Karl Storz Recent Development Table 136. Verathon Company Information Table 137. Verathon Business Overview Table 138. Verathon Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Verathon Interventional Pulmonology Device Product Portfolio Table 140. Verathon Recent Development Table 141. Well Lead Company Information Table 142. Well Lead Business Overview Table 143. Well Lead Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Well Lead Interventional Pulmonology Device Product Portfolio Table 145. Well Lead Recent Development Table 146. TuoRen Company Information Table 147. TuoRen Business Overview Table 148. TuoRen Interventional Pulmonology Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. TuoRen Interventional Pulmonology Device Product Portfolio Table 150. TuoRen Recent Development Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Interventional Pulmonology Device Distributors List Table 154. Interventional Pulmonology Device Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Interventional Pulmonology Device Product Image Figure 2. Global Interventional Pulmonology Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Interventional Pulmonology Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Interventional Pulmonology Device Sales (2021-2032) & (k units) Figure 5. Global Interventional Pulmonology Device Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Interventional Pulmonology Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Bronchoscope Image Figure 10. Pleuroscopy Image Figure 11. Respiratory Endotherapy Devices Image Figure 12. IP Therapeutic Device Image Figure 13. Tracheostomy Tube Image Figure 14. Global Interventional Pulmonology Device Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Interventional Pulmonology Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Interventional Pulmonology Device Sales Volume Share by Type (2021-2032) Figure 17. Global Interventional Pulmonology Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Interventional Pulmonology Device Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Interventional Pulmonology Device Sales Value Share by Type (2021-2032) Figure 20. Hospital and Clinic Image Figure 21. Ambulatory Surgical Centers Image Figure 22. Global Interventional Pulmonology Device Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Interventional Pulmonology Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Interventional Pulmonology Device Sales Volume Share by Application (2021-2032) Figure 25. Global Interventional Pulmonology Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Interventional Pulmonology Device Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Interventional Pulmonology Device Sales Value Share by Application (2021-2032) Figure 28. Global Interventional Pulmonology Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Interventional Pulmonology Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Interventional Pulmonology Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Interventional Pulmonology Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Interventional Pulmonology Device Sales Value (2021-2032) & (US$ Million) Figure 33. North America Interventional Pulmonology Device Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Interventional Pulmonology Device Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Interventional Pulmonology Device Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Interventional Pulmonology Device Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Interventional Pulmonology Device Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Interventional Pulmonology Device Sales Value (2021-2032) & (US$ Million) Figure 39. South America Interventional Pulmonology Device Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Interventional Pulmonology Device Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Interventional Pulmonology Device Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Interventional Pulmonology Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Interventional Pulmonology Device Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Interventional Pulmonology Device Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Bronchoscope
  • Pleuroscopy
  • Respiratory Endotherapy Devices
  • IP Therapeutic Device
  • Tracheostomy Tube
Applications
  • Hospital and Clinic
  • Ambulatory Surgical Centers
Companies covered
  • Boston Scientific
  • Olympus
  • Medtronic
  • Ambu A/S
  • Pentax (HOYA)
  • Micro Tech
  • Fujifilm
  • CONMED
  • Teleflex Medical
  • ICU Medical
  • Medi-Globe
  • Merit Medical Systems
  • TRACOE medical
  • Karl Storz
  • Verathon
  • Well Lead
  • TuoRen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Interventional Pulmonology Device Sales Value (2021-2032)
  4. 1.2.2 Global Interventional Pulmonology Device Sales Volume (2021-2032)
  5. 1.2.3 Global Interventional Pulmonology Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Interventional Pulmonology Device Market Dynamics
  1. 2.1 Interventional Pulmonology Device Industry Trends
  2. 2.2 Interventional Pulmonology Device Industry Drivers
  3. 2.3 Interventional Pulmonology Device Industry Opportunities and Challenges
  4. 2.4 Interventional Pulmonology Device Industry Restraints
3 Interventional Pulmonology Device Market by Company
  1. 3.1 Global Interventional Pulmonology Device Company Revenue Ranking in 2025
  2. 3.2 Global Interventional Pulmonology Device Revenue by Company (2021-2026)
  3. 3.3 Global Interventional Pulmonology Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Interventional Pulmonology Device Average Price by Company (2021-2026)
  5. 3.5 Global Interventional Pulmonology Device Company Ranking (2024-2026)
  6. 3.6 Global Interventional Pulmonology Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Interventional Pulmonology Device Company Product Type and Application
  8. 3.8 Global Interventional Pulmonology Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Interventional Pulmonology Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Interventional Pulmonology Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Interventional Pulmonology Device Market by Type
  1. 4.1 Interventional Pulmonology Device Type Introduction
  2. 4.1.1 Bronchoscope
  3. 4.1.2 Pleuroscopy
  4. 4.1.3 Respiratory Endotherapy Devices
  5. 4.1.4 IP Therapeutic Device
  6. 4.1.5 Tracheostomy Tube
  7. 4.2 Global Interventional Pulmonology Device Sales Volume by Type
  8. 4.2.1 Global Interventional Pulmonology Device Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Interventional Pulmonology Device Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Interventional Pulmonology Device Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Interventional Pulmonology Device Sales Value by Type
  12. 4.3.1 Global Interventional Pulmonology Device Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Interventional Pulmonology Device Sales Value by Type (2021-2032)
  14. 4.3.3 Global Interventional Pulmonology Device Sales Value Share by Type (2021-2032)
5 Interventional Pulmonology Device Market by Application
  1. 5.1 Interventional Pulmonology Device Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Ambulatory Surgical Centers
  4. 5.2 Global Interventional Pulmonology Device Sales Volume by Application
  5. 5.2.1 Global Interventional Pulmonology Device Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Interventional Pulmonology Device Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Interventional Pulmonology Device Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Interventional Pulmonology Device Sales Value by Application
  9. 5.3.1 Global Interventional Pulmonology Device Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Interventional Pulmonology Device Sales Value by Application (2021-2032)
  11. 5.3.3 Global Interventional Pulmonology Device Sales Value Share by Application (2021-2032)
6 Interventional Pulmonology Device Regional Sales and Value Analysis
  1. 6.1 Global Interventional Pulmonology Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Interventional Pulmonology Device Sales by Region (2021-2032)
  3. 6.2.1 Global Interventional Pulmonology Device Sales by Region: 2021-2026
  4. 6.2.2 Global Interventional Pulmonology Device Sales by Region (2027-2032)
  5. 6.3 Global Interventional Pulmonology Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Interventional Pulmonology Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Interventional Pulmonology Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Interventional Pulmonology Device Sales Value by Region (2027-2032)
  9. 6.5 Global Interventional Pulmonology Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Interventional Pulmonology Device Sales Value (2021-2032)
  12. 6.6.2 North America Interventional Pulmonology Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Interventional Pulmonology Device Sales Value (2021-2032)
  15. 6.7.2 Europe Interventional Pulmonology Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Interventional Pulmonology Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Interventional Pulmonology Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Interventional Pulmonology Device Sales Value (2021-2032)
  21. 6.9.2 South America Interventional Pulmonology Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Interventional Pulmonology Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Interventional Pulmonology Device Sales Value Share by Country, 2025 VS 2032
7 Interventional Pulmonology Device Country-level Sales and Value Analysis
  1. 7.1 Global Interventional Pulmonology Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Interventional Pulmonology Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Interventional Pulmonology Device Sales by Country (2021-2032)
  4. 7.3.1 Global Interventional Pulmonology Device Sales by Country (2021-2026)
  5. 7.3.2 Global Interventional Pulmonology Device Sales by Country (2027-2032)
  6. 7.4 Global Interventional Pulmonology Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Interventional Pulmonology Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Interventional Pulmonology Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Interventional Pulmonology Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Interventional Pulmonology Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Interventional Pulmonology Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boston Scientific
  2. 8.1.1 Boston Scientific Company Information
  3. 8.1.2 Boston Scientific Business Overview
  4. 8.1.3 Boston Scientific Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boston Scientific Interventional Pulmonology Device Product Portfolio
  6. 8.1.5 Boston Scientific Recent Developments
  7. 8.2 Olympus
  8. 8.2.1 Olympus Company Information
  9. 8.2.2 Olympus Business Overview
  10. 8.2.3 Olympus Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Olympus Interventional Pulmonology Device Product Portfolio
  12. 8.2.5 Olympus Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Interventional Pulmonology Device Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Ambu A/S
  20. 8.4.1 Ambu A/S Company Information
  21. 8.4.2 Ambu A/S Business Overview
  22. 8.4.3 Ambu A/S Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ambu A/S Interventional Pulmonology Device Product Portfolio
  24. 8.4.5 Ambu A/S Recent Developments
  25. 8.5 Pentax (HOYA)
  26. 8.5.1 Pentax (HOYA) Company Information
  27. 8.5.2 Pentax (HOYA) Business Overview
  28. 8.5.3 Pentax (HOYA) Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pentax (HOYA) Interventional Pulmonology Device Product Portfolio
  30. 8.5.5 Pentax (HOYA) Recent Developments
  31. 8.6 Micro Tech
  32. 8.6.1 Micro Tech Company Information
  33. 8.6.2 Micro Tech Business Overview
  34. 8.6.3 Micro Tech Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Micro Tech Interventional Pulmonology Device Product Portfolio
  36. 8.6.5 Micro Tech Recent Developments
  37. 8.7 Fujifilm
  38. 8.7.1 Fujifilm Company Information
  39. 8.7.2 Fujifilm Business Overview
  40. 8.7.3 Fujifilm Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Fujifilm Interventional Pulmonology Device Product Portfolio
  42. 8.7.5 Fujifilm Recent Developments
  43. 8.8 CONMED
  44. 8.8.1 CONMED Company Information
  45. 8.8.2 CONMED Business Overview
  46. 8.8.3 CONMED Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CONMED Interventional Pulmonology Device Product Portfolio
  48. 8.8.5 CONMED Recent Developments
  49. 8.9 Teleflex Medical
  50. 8.9.1 Teleflex Medical Company Information
  51. 8.9.2 Teleflex Medical Business Overview
  52. 8.9.3 Teleflex Medical Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Teleflex Medical Interventional Pulmonology Device Product Portfolio
  54. 8.9.5 Teleflex Medical Recent Developments
  55. 8.10 ICU Medical
  56. 8.10.1 ICU Medical Company Information
  57. 8.10.2 ICU Medical Business Overview
  58. 8.10.3 ICU Medical Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 ICU Medical Interventional Pulmonology Device Product Portfolio
  60. 8.10.5 ICU Medical Recent Developments
  61. 8.11 Medi-Globe
  62. 8.11.1 Medi-Globe Company Information
  63. 8.11.2 Medi-Globe Business Overview
  64. 8.11.3 Medi-Globe Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Medi-Globe Interventional Pulmonology Device Product Portfolio
  66. 8.11.5 Medi-Globe Recent Developments
  67. 8.12 Merit Medical Systems
  68. 8.12.1 Merit Medical Systems Company Information
  69. 8.12.2 Merit Medical Systems Business Overview
  70. 8.12.3 Merit Medical Systems Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Merit Medical Systems Interventional Pulmonology Device Product Portfolio
  72. 8.12.5 Merit Medical Systems Recent Developments
  73. 8.13 TRACOE medical
  74. 8.13.1 TRACOE medical Company Information
  75. 8.13.2 TRACOE medical Business Overview
  76. 8.13.3 TRACOE medical Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 TRACOE medical Interventional Pulmonology Device Product Portfolio
  78. 8.13.5 TRACOE medical Recent Developments
  79. 8.14 Karl Storz
  80. 8.14.1 Karl Storz Company Information
  81. 8.14.2 Karl Storz Business Overview
  82. 8.14.3 Karl Storz Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Karl Storz Interventional Pulmonology Device Product Portfolio
  84. 8.14.5 Karl Storz Recent Developments
  85. 8.15 Verathon
  86. 8.15.1 Verathon Company Information
  87. 8.15.2 Verathon Business Overview
  88. 8.15.3 Verathon Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Verathon Interventional Pulmonology Device Product Portfolio
  90. 8.15.5 Verathon Recent Developments
  91. 8.16 Well Lead
  92. 8.16.1 Well Lead Company Information
  93. 8.16.2 Well Lead Business Overview
  94. 8.16.3 Well Lead Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Well Lead Interventional Pulmonology Device Product Portfolio
  96. 8.16.5 Well Lead Recent Developments
  97. 8.17 TuoRen
  98. 8.17.1 TuoRen Company Information
  99. 8.17.2 TuoRen Business Overview
  100. 8.17.3 TuoRen Interventional Pulmonology Device Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 TuoRen Interventional Pulmonology Device Product Portfolio
  102. 8.17.5 TuoRen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Interventional Pulmonology Device Value Chain Analysis
  2. 9.1.1 Interventional Pulmonology Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Interventional Pulmonology Device Sales Mode & Process
  6. 9.2 Interventional Pulmonology Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Interventional Pulmonology Device Distributors
  9. 9.2.3 Interventional Pulmonology Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst